Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRGF Incubation for Corneal Endothelial Grafts
NCT06261346Recruiting
- Sponsor
- University of Miami
- Start
- Jul 2024
- Primary completion
- Oct 2027
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Trial of PRGF-Endoret in Fuchs endothelial dystrophy (FED) and corneal edema (2 arms), sponsored by University of Miami. Primary endpoint: Change in endothelial cell percentage at 6 months. Started Jul 2024; status: recruiting.
02
Drugs
PRGF-Endoret
03
Conditions
Fuchs endothelial dystrophy (FED)corneal edema
Beyond the preview
Go deeper on NCT06261346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06261346.